CAP is proud to partner with Novella Clinical as its preferred vendor for data management, biostatistics, EDC, and safety services. In addition, Novella is CAP’s global partner for worldwide study management services and support.
As an independent business unit of Quintiles, Novella brings world-leading global resources and specialty services, if needed by our customers.
Within oncology, CAP and Novella have worked on more than 350 programs in 46 countries to date, 44 of which are currently active across 5 continents. Our team will formulate a detailed and clinically integrated plan of action from the onset of a study to include country approvals, local nuances, protocol implementation and the effective capture of subject outcomes through our effective and consistent data collection and cleaning process. Our team will provide consistent and effective communication consolidated globally, working in an orderly and precise fashion, and have the flexibility to re-prioritize if/when necessary.
Biomodels is unique in that it provides its clients access to world class technologies and predictive models through a series of collaborative relationships with leading academic researchers and institutions. As a result, Biomodels’ clients receive superior research together with the confidence of knowing their results can be relied upon to assess the potential for clinical success. Many of the world’s largest and most respected life science companies, as well as dozens of small and mid-size companies regularly call on Biomodels for the best in outsourced preclinical research.